Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

During the Trading Day
23.14 -0.29 / -1.24%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
23.23 +0.09 / +0.39%
 
Volume: 37.2K
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close23.43
Today’s open23.24
Day’s range22.43 - 23.33
Volume920,803
Average volume (3 months)1,359,643
Market cap$3.0B
Dividend yield--
Data as of 4:00pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+14.20%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book71.23

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc+0.19+0.27%
RDUSRadius Health Inc+1.85+2.52%
NVAXNovavax Inc+0.18+1.51%
OPHTOphthotech Corp+0.23+0.34%
Data as of 4:00pm ET, 07/30/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts